{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:31:48Z","timestamp":1783690308360,"version":"3.55.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:sec id=\"ab-drv230003-4\"><jats:title>Importance<\/jats:title><jats:p>Chemotherapy-induced <jats:italic>pseudocellulitis<\/jats:italic> is an ill-defined term for a poorly understood phenomenon. Encompassing a myriad of cellulitis-mimicking oncologic adverse cutaneous drug reactions (ACDRs), pseudocellulitis may be difficult to diagnosis, and the lack of treatment guidance may mean unnecessary antibiotic exposure and interruptions to oncologic care.<\/jats:p><\/jats:sec><jats:sec id=\"ab-drv230003-5\"><jats:title>Objectives<\/jats:title><jats:p>To use case reports to characterize the various cellulitis-mimicking reactions caused by chemotherapeutic medications, to understand how these reactions affect patient care (ie, antibiotic exposure and interruptions to oncologic treatment), and to make recommendations for improved diagnosis and care of patients with chemotherapy-induced pseudocellulitis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-drv230003-6\"><jats:title>Evidence Review<\/jats:title><jats:p>A systematic review of case reports of patients with pseudocellulitis was performed. Reports were identified through database searches using PubMed and Embase, with subsequent reference searches. Included publications described at least 1 case of chemotherapy-induced ACDR and used the term <jats:italic>pseudocellulitis<\/jats:italic> or showed evidence of cellulitis mimicry. Cases of radiation recall dermatitis were excluded. Data were extracted from a total of 32 publications representing 81 patients diagnosed with pseudocellulitis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-drv230003-7\"><jats:title>Findings<\/jats:title><jats:p>Of the 81 cases (median [range] age, 67 [36-80] years; 44 [54%] male patients), most were associated with gemcitabine use; pemetrexed use was reported less frequently. Only 39 were considered to be true chemotherapy-induced pseudocellulitis. These cases resembled infectious cellulitis and did not meet diagnostic criteria for any known diagnoses; therefore, these were described solely as pseudocellulitis. Of this group, 26 patients (67%) had been administered antibiotics before the correct diagnosis was made, and 14 patients (36%) experienced interruptions to their oncologic treatment plans.<\/jats:p><\/jats:sec><jats:sec id=\"ab-drv230003-8\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This systematic review found a variety of chemotherapy-induced ACDRs that mimic infectious cellulitis, including a group of reactions termed <jats:italic>pseudocellulitis<\/jats:italic> that do not meet criteria for other diagnoses. A more universally accepted definition and clinical research on chemotherapy-induced pseudocellulitis would allow for more accurate diagnosis, effective treatment, antibiotic stewardship, and continuation of oncologic treatment.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamadermatol.2023.1735","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T15:34:40Z","timestamp":1687966480000},"page":"870","source":"Crossref","is-referenced-by-count":7,"title":["Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure"],"prefix":"10.1001","volume":"159","author":[{"given":"Leah D.","family":"Kovacs","sequence":"first","affiliation":[{"name":"University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"O\u2019Donoghue","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Cogen","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"drv230003r1","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1097\/01.mjt.0000522273.81146.49","article-title":"Recurrent lower extremity pseudocellulitis.","volume":"19","author":"Korniyenko","year":"2012","journal-title":"Am J Ther"},{"issue":"9","key":"drv230003r2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"3","key":"drv230003r3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/01.COC.0000017782.24458.DD","article-title":"Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature.","volume":"26","author":"Azzoli","year":"2003","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"drv230003r4","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.jaad.2001.07.001","article-title":"Gemcitabine-associated scleroderma-like changes of the lower extremities.","volume":"51","author":"Bessis","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"drv230003r5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/000155501317208381","article-title":"Gemcitabine-induced acute lipodermatosclerosis-like reaction.","volume":"81","author":"Chu","year":"2001","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"drv230003r6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jdcr.2017.02.014","article-title":"Gemcitabine-associated acute lipodermatosclerosis-like eruption: an underrecognized phenomenon.","volume":"3","author":"Mittal","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"5","key":"drv230003r7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1177\/1078155218788709","article-title":"A case of gemcitabine-related acute lipodermatosclerosis.","volume":"25","author":"Nyckowski","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"3","key":"drv230003r8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/15569520903046942","article-title":"Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer.","volume":"28","author":"Li","year":"2009","journal-title":"Cutan Ocul Toxicol"},{"key":"drv230003r9","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X18809268","article-title":"Gemcitabine-induced skin necrosis.","volume":"6","author":"Haydock","year":"2018","journal-title":"SAGE Open Med Case Rep"},{"issue":"4","key":"drv230003r10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4103\/ijmpo.ijmpo_119_17","article-title":"Gemcitabine-associated pseudocellulitis: a great mimicker.","volume":"39","author":"Ahuja","year":"2018","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"4","key":"drv230003r11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jdcr.2015.04.007","article-title":"Gemcitabine-induced pseudocellulitis in a patient with non-small cell lung carcinoma.","volume":"1","author":"Asemota","year":"2015","journal-title":"JAAD Case Rep"},{"issue":"5","key":"drv230003r12","doi-asserted-by":"publisher","first-page":"e703","DOI":"10.3747\/co.26.5007","article-title":"Gemcitabine-induced pseudocellulitis: a case report and review of the literature.","volume":"26","author":"Bami","year":"2019","journal-title":"Curr Oncol"},{"issue":"5","key":"drv230003r13","first-page":"E20","article-title":"Gemcitabine-induced pseudocellulitis.","volume":"102","author":"Caplan","year":"2018","journal-title":"Cutis"},{"issue":"1","key":"drv230003r14","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1097\/MJT.0000000000000024","article-title":"Gemcitabine-induced pseudocellulitis in a patient with recurrent lymphedema: a case report and review of the current literature.","volume":"23","author":"Curtis","year":"2016","journal-title":"Am J Ther"},{"issue":"5","key":"drv230003r15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/1078155214531610","article-title":"Recurrent pseudocellulitis due to gemcitabine: underrecognized and underreported?","volume":"21","author":"Dasanu","year":"2015","journal-title":"J Oncol Pharm Pract"},{"issue":"7","key":"drv230003r16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/1078155217719584","article-title":"Gemcitabine associated pseudocellulitis: a missed diagnosis.","volume":"24","author":"Gill","year":"2018","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"drv230003r17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/MJT.0b013e3182204ffe","article-title":"Gemcitabine-associated \u201cpseudocellulitis\u201d and \u201cpseudosepsis\u201d: a case report and review of the literature.","volume":"20","author":"Obeid","year":"2013","journal-title":"Am J Ther"},{"issue":"4","key":"drv230003r18","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.4103\/0973-1482.148711","article-title":"Erysipeloid rash: a rare adverse event induced by gemcitabine.","volume":"11","author":"Ruiz-Casado","year":"2015","journal-title":"J Cancer Res Ther"},{"issue":"12","key":"drv230003r19","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s11606-012-2101-x","article-title":"Gemcitabine associated pseudocellulitis.","volume":"27","author":"Singh","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"2","key":"drv230003r20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1078155216635852","article-title":"A rash diagnosis: gemcitabine-associated pseudocellulitis.","volume":"23","author":"Strouse","year":"2017","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"drv230003r21","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1086\/520684","article-title":"Gemcitabine-related \u201cpseudocellulitis\u201d: report of 2 cases and review of the literature.","volume":"45","author":"Tan","year":"2007","journal-title":"Clin Infect Dis"},{"key":"drv230003r22","doi-asserted-by":"publisher","first-page":"ii27","DOI":"10.1093\/annonc\/mdw199.118","article-title":"Gemcitabine-induced pseudocellulitis in patients with pancreatic adenocarcinoma or cholangiocarcinoma.","volume":"27","author":"Una Cidon","year":"2016","journal-title":"Ann Oncol"},{"issue":"3","key":"drv230003r23","doi-asserted-by":"publisher","first-page":"AB232","DOI":"10.1016\/j.jaad.2018.05.928","article-title":"Pseudocellulitis and gemcitabine, a recently described entity: case report and literature review.","volume":"79","author":"Vigil","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"drv230003r24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00001813-200001000-00003","article-title":"Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine: a report of three cases.","volume":"11","author":"Brandes","year":"2000","journal-title":"Anticancer Drugs"},{"issue":"6","key":"drv230003r25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/jdv.2006.20.issue-6","article-title":"Erysipeloid skin toxicity induced by gemcitabine.","volume":"20","author":"Zustovich","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"drv230003r26","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/JTO.0b013e318207f788","article-title":"A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed.","volume":"6","author":"D\u2019Angelo","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"3","key":"drv230003r27","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/JTO.0000000000000426","article-title":"Lipodermatosclerosis secondary to pemetrexed use.","volume":"10","author":"Shuster","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"1","key":"drv230003r28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jdcr.2016.11.001","article-title":"Pemetrexed-induced eccrine squamous syringometaplasia manifesting as pseudocellulitis (in a patient with non-small cell lung cancer).","volume":"3","author":"Santosa","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"8","key":"drv230003r29","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/ced.2017.42.issue-8","article-title":"Pemetrexed-induced lower limb pseudocellulitis.","volume":"42","author":"Liau","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"drv230003r30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/kjm2.v36.11","article-title":"Pemetrexed-induced pseudocellulitis.","volume":"36","author":"Lo","year":"2020","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"drv230003r31","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/DAD.0000000000000645","article-title":"Pemetrexed-induced pseudocellulitis reaction with eosinophilic infiltrate on skin biopsy.","volume":"39","author":"Tracey","year":"2017","journal-title":"Am J Dermatopathol"},{"issue":"267","key":"drv230003r32","first-page":"81","article-title":"Pemetrexed-induced pseudocellulitis: a rare cutaneous adverse reaction to multi-targeted antifolate therapy.","author":"Wollina","year":"2017","journal-title":"Georgian Med News"},{"key":"drv230003r33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2010.01.003","article-title":"Painful generalized erythematous patches: a severe and unusual cutaneous reaction to pemetrexed.","author":"Vitiello","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"drv230003r34","doi-asserted-by":"publisher","first-page":"163.e1","DOI":"10.1016\/j.jaad.2012.03.024","article-title":"Lower limb cellulitis and its mimics: part I. Lower limb cellulitis.","volume":"67","author":"Hirschmann","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"drv230003r35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/dth.2011.24.issue-2","article-title":"Cellulitis: diagnosis and management.","volume":"24","author":"Bailey","year":"2011","journal-title":"Dermatol Ther"},{"issue":"3","key":"drv230003r36","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jid.2017.09.022","article-title":"Skin surface temperatures measured by thermal imaging aid in the diagnosis of cellulitis.","volume":"138","author":"Ko","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"6","key":"drv230003r37","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3322\/caac.v71.6","article-title":"Antibiotic resistance in the patient with cancer: escalating challenges and paths forward.","volume":"71","author":"Nanayakkara","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"drv230003r39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.idc.2020.10.001","article-title":"Distinguishing cellulitis from its noninfectious mimics: approach to the red leg.","volume":"35","author":"Garcia","year":"2021","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"drv230003r40","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jaad.2019.09.084","article-title":"A survey-based study of diagnostic and treatment concordance in standardized cases of cellulitis and pseudocellulitis via teledermatology.","volume":"82","author":"Korman","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"drv230003r41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/jamadermatol.2017.6197","article-title":"Outcomes of early dermatology consultation for inpatients diagnosed with cellulitis.","volume":"154","author":"Li","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"drv230003r42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40257-021-00659-8","article-title":"Cellulitis: a review of current practice guidelines and differentiation from pseudocellulitis.","volume":"23","author":"Boettler","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"drv230003r38","volume-title":"Dermatology Essentials","author":"Bolognia","year":"2022","edition":"2nd ed"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2806306\/jamadermatology_kovacs_2023_rv_230003_1692117322.71783.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T15:03:13Z","timestamp":1692198193000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2806306"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2023.1735","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}